Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.41 |
| ▸ | PPARG | P37231 | 3/20 | 0.41 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.41 |
| ▸ | RXRA | P19793 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.41 |
| ▸ | CNR1 | P21554 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 3/20 | 0.41 |
| ▸ | F7 | P08709 | 3/20 | 0.39 |
| ▸ | F3 | P13726 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | PPARD | Q03181 | 2/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13003230 | 0.79 | ALDH1A1 (0.42) | PTGS1ALDH1A1CYP19A1PPARGOXER1 | |
| SCHEMBL10638107 | 0.78 | ICMT (0.43) | TDP1ICMT | |
| SCHEMBL10706269 | 0.78 | ICMT (0.43) | TDP1ICMT | |
| SCHEMBL10706505 | 0.78 | ICMT (0.43) | TDP1ICMT | |
| SCHEMBL10631797 | 0.78 | ICMT (0.43) | TDP1ICMT | |
| SCHEMBL18944620 | 0.77 | ALDH1A1 (0.52) | PTGS1ALDH1A1CYP19A1PPARGOXER1 | |
| SCHEMBL16926634 | 0.74 | PPARA (0.46) | PTGS1ALDH1A1CYP19A1PPARGOXER1 | |
| SCHEMBL3740810 | 0.74 | ALDH1A1 (0.56) | PTGS1ALDH1A1CYP19A1PPARGOXER1 | |
| SCHEMBL9880633 | 0.74 | ALDH1A1 (0.47) | PTGS1ALDH1A1CYP19A1PPARGOXER1 | |
| SCHEMBL19921001 | 0.74 | ALDH1A1 (0.54) | PTGS1ALDH1A1CYP19A1PPARGOXER1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2217224-B1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | BASF AS (NO) | 2019-05-08 | — | — | EP | disclosed |
| US-8741966-B2 | Lipid compounds for use in cosmetic products, as food supplement or as a medicament | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-06-03 | — | — | US | disclosed |
| US-8741966-B2 | Lipid compounds for use in cosmetic products, as food supplement or as a medicament | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-06-03 | — | — | US | disclosed |
| US-8741966-B2 | Lipid compounds for use in cosmetic products, as food supplement or as a medicament | PRONOVA BIOPHARMA NORGE AS (NO) | 2014-06-03 | — | — | US | disclosed |
| US-20100280109-A1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-11-04 | — | — | US | disclosed |
| US-20100280109-A1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-11-04 | — | — | US | disclosed |
| US-20100280109-A1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2010-11-04 | — | — | US | disclosed |
| EP-2217224-A1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | Pronova BioPharma Norge AS (NO) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009061208-A1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | PRONOVA BIOPHARMA NORGE AS (NO) | 2009-05-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100280109-A1 | LIPID COMPOUNDS FOR USE IN COSMETIC PRODUCTS, AS FOOD SUPPLEMENT OR AS A MEDICAMENT | SGMS1, SGMS2, C1S | PTGS1 384/4885ALDH1A1 327/4885CYP19A1 418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.